//
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up
Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT